Patenting Human Embryonic Stem Cells in the European Union Context: An Updated Analysis of a Complex Issue-Reference-Cited by-同舟云学术

Patenting Human Embryonic Stem Cells in the European Union Context: An Updated Analysis of a Complex Issue

Published:2017 Issue: Volume: Page:263-273
ISSN:2365-4198
Container-title:Stem Cells in Clinical Applications
language:
Short-container-title:

Author:

de Miguel Beriain Iñigo

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-59165-0_12

Reference22 articles.

1. Alikani M, Munné S (2005) Nonviable human pre-implantation embryos as a source of stem cells for research and potential therapy. Stem Cell Rev Rep 1(4):337–343

2. Chung Y et al (2008) Human embryonic stem cell lines generated without embryo destruction. Cell Stem Cell 2:113–117

3. Condic ML (2014) Totipotency: what it is and what it is not. Stem Cells Dev 23(8):796–812. doi: 10.1089/scd.2013.0364

4. Condic ML, Lee P, George RG (2009) Ontological and ethical implications of direct nuclear reprogramming: response to Magill and Neaves. Kennedy Inst Ethics J 19:33–40

5. Dannreuther A (2014) The CJEU clarifies when stem cells can be patented in Europe, Friday, 19 December 2014, EU Law Analysis Expert insight into EU law developments. http://eulawanalysis.blogspot.com/2014/12/the-cjeu-clarifies-when-stem-cells-can.html . Accessed 21 Sept 2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human stem-cell-derived embryo models: When bioethical normativity meets biological ontology;Developmental Biology;2024-04

2. Synthetic embryos: a new venue in ethical research;Reproduction;2023-02-23

3. Patentability of time-lapse monitoring has nothing to do with human dignity: A response to Alain Pottage;Reproductive BioMedicine Online;2018-10